Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,341 GBp
Change Today +9.50 / 0.71%
Volume 8.8M
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc Dunoyer

AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
631,921,000 GBP


Mr. Marc Dunover has been the Chief Financial Officer at AstraZeneca PLC since November 1, 2013. Mr. Dunover served as Executive Vice President of Global Portfolio & Product Strategy at AstraZeneca PLC from June 2013 to October 2013. Mr. Dunover served as the Global Head of Rare Diseases Unit of JCR Pharmaceuticals Co., Ltd. He served as Head of Rare Diseases Unit at GlaxoSmithKline since February 2010. He served as President of Asia Pacific/Japan at GlaxoSmithKline ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Chief Financial Officer and Executive Director


Ecole des Hautes Etudes Commerciales de Montreal
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

Salary680,000 GBP
Bonus1,016,000 GBP
Total Annual Compensation1,696,000 GBP

Stock Options*

All Other Compensation225,000 GBP

Total Compensation*

Total Annual Cash Compensation1,921,000 GBP
Total Short Term Compensation1,696,000 GBP
Other Long Term Compensation225,000 GBP
Total Calculated Compensation1,921,000 GBP
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,340.50 GBp +9.50


George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at